Expertise in
21
conditions

Dr. Steven Brem

Neurosurgery
Trustees Of The University Of Pennsylvania
3400 Spruce St, 
Philadelphia, PA 
Expertise in
21
conditions
Trustees Of The University Of Pennsylvania
3400 Spruce St, 
Philadelphia, PA 

Overview

Steven Brem is a Neurosurgery provider practicing medicine in Philadelphia, Pennsylvania.

Dr. Brem is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, Awake Craniotomy, and Gastrostomy.

He is actively involved in clinical research, co-authoring 116 peer reviewed articles and participating in 7 clinical trials.

Specialties

Neurosurgery

Licenses

Neurological Surgery in PA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

Trustees of the University of Pennsylvania
3400 Spruce St, Philadelphia, PA 19104

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

An Open-Label, Multi-Center Trial of INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With REGN2810 in Subjects With Newly-Diagnosed Glioblastoma (GBM)
An Open-Label, Multi-Center Trial of INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With REGN2810 in Subjects With Newly-Diagnosed Glioblastoma (GBM)
Enrollment Status: Active_not_recruiting
Publish Date: May 04, 2026
Intervention Type: Biological, Drug, Radiation
Study Drugs: INO-5401, INO-9012, Cemiplimab, Temozolomide
Study Phase: Phase 1/Phase 2
Vigilant ObservatIon of GlIadeL WAfer ImplaNT (VIGILANT) Registry: A Multicenter, Observational Registry to Collect Information on the Safety and Effectiveness of Gliadel® Wafer (Carmustine Implant) Used in Usual Medical Practice
Vigilant ObservatIon of GlIadeL WAfer ImplaNT (VIGILANT) Registry: A Multicenter, Observational Registry to Collect Information on the Safety and Effectiveness of Gliadel® Wafer (Carmustine Implant) Used in Usual Medical Practice
Enrollment Status: Completed
Publish Date: November 10, 2025
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Enrollment Status: Completed
Publish Date: October 31, 2025
Intervention Type: Device, Other
Study Phase: Phase 3
Phase I Study of Neoadjuvant GMCI Plus Immune Checkpoint Inhibitor Combined With Standard of Care for Newly Diagnosed High-Grade Gliomas
Phase I Study of Neoadjuvant GMCI Plus Immune Checkpoint Inhibitor Combined With Standard of Care for Newly Diagnosed High-Grade Gliomas
Enrollment Status: Completed
Publish Date: February 14, 2025
Intervention Type: Radiation, Biological, Other, Drug
Study Drugs: AdV-tk, Valacyclovir, Temozolomide, Nivolumab
Study Phase: Phase 1
Validation of Edema-invariant Multi-shell High Angular Resolution Diffusion Imaging (msHARDI)-Based Tractography With Intra-operative Cortical Stimulation
Validation of Edema-invariant Multi-shell High Angular Resolution Diffusion Imaging (msHARDI)-Based Tractography With Intra-operative Cortical Stimulation
Enrollment Status: Completed
Publish Date: April 18, 2023
Intervention Type: Other
An Open-Label Non-Randomized, Multi-Center Phase-2 Study of Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma
An Open-Label Non-Randomized, Multi-Center Phase-2 Study of Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma
Enrollment Status: Completed
Publish Date: October 24, 2022
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
Enrollment Status: Terminated
Publish Date: February 07, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 2/Phase 3
View 6 Less Clinical Trials

116 Total Publications

Reply to "Ascertainment of overall survival and the proposed molecular grading tier in IDH-mutant astrocytoma".
Reply to "Ascertainment of overall survival and the proposed molecular grading tier in IDH-mutant astrocytoma".
Journal: Neuro-oncology
Published: August 18, 2026
Similar Doctors
Expertise in
28
conditions
Expertise in
28
conditions
Referral may be required
Before you request

Penn Gamma Knife Center

801 Spruce Street, Spruce Building, 1st Floor, 
Philadelphia, PA 
 (2.0 miles away)
215-662-3487
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Donald O'rourke is a Neurosurgery provider practicing medicine in Philadelphia, Pennsylvania. Dr. O'rourke is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, Awake Craniotomy, and Gastrostomy. Dr. O'rourke is board certified in Neurological Surgery, 1998. Dr. O'rourke is currently accepting new patients.

Expertise in
39
conditions
Expertise in
39
conditions
Referral may be required
Before you request

Vickie And Jack Farber Institute For Neuroscience At Jefferson

380 North Oxford Valley Road, 
Langhorne, PA 
 (23.5 miles away)
215-757-3980
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Pascal Jabbour is a Neurosurgery provider practicing medicine in Langhorne, Pennsylvania. Dr. Jabbour is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Brain Aneurysm, Stroke, Subarachnoid Hemorrhage, Thrombectomy, and Stent Placement. Dr. Jabbour is board certified in American Board Of Neurological Surgery and Neurological Surgery. Dr. Jabbour is currently accepting new patients.

Expertise in
15
conditions
Dr. Amer F. Samdani
Neurosurgery
Expertise in
15
conditions
Dr. Amer F. Samdani
Neurosurgery
Referral may be required

St. Christopher's Hospital For Children

160 E Erie Ave, 
Philadelphia, PA 
 (5.4 miles away)
215-427-5000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Amer Samdani is a Neurosurgery provider practicing medicine in Philadelphia, Pennsylvania. Dr. Samdani is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Scoliosis, Adolescent Idiopathic Scoliosis, Kyphosis, Spinal Fusion, and Osteotomy. Dr. Samdani is board certified in American Board Of Neurological Surgery. Dr. Samdani is currently accepting new patients.

Frequently Asked Questions about Dr. Steven Brem

How do I make an appointment with Dr. Steven Brem?

You can book an appointment with Dr. Steven Brem by calling their office at 215-662-3487. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Steven Brem a top-rated expert for Glioblastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Steven Brem is classified as an Elite expert for Glioblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Steven Brem specialize in?

While Dr. Steven Brem is a Neurosurgery, they have specific expertise in Glioblastoma, Astrocytoma, and Glioma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurosurgery.

Does Dr. Steven Brem participate in research or clinical trials?

Yes. Dr. Steven Brem has published 116 articles and abstracts on conditions like Glioblastoma. You can view a list of Dr. Steven Brem's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Steven Brem accept my insurance?

Dr. Steven Brem accepts most major insurance plans, including Humana. We recommend calling the office directly at 215-662-3487 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Brem's expertise for a condition
ConditionClose
View All 10 Distinguished Conditions
View All 19 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile